|
US5082669A
(en)
|
1989-07-20 |
1992-01-21 |
Dainippon Pharmaceutical Co., Ltd. |
Rapid-releasing oral particle pharmaceutical preparation with unpleasant taste masked
|
|
SE8904296D0
(sv)
|
1989-12-21 |
1989-12-21 |
Pharmacia Ab |
Transdermal system
|
|
ATE196427T1
(de)
|
1993-12-06 |
2000-10-15 |
Takeda Chemical Industries Ltd |
Zusammensetzung mit verbesserter wasserlöslichkeit, enthaltend eine wasserunlösliche oder an wasser schwerunlösliche verbindung
|
|
DE19518810A1
(de)
|
1995-05-26 |
1996-11-28 |
Bayer Ag |
Nasal-Applikator
|
|
CN1106888C
(zh)
|
1998-03-10 |
2003-04-30 |
瓦卢瓦股份有限公司 |
容器、容器的灌注方法及容器中流体制品的分配装置
|
|
JP2000178184A
(ja)
|
1998-12-17 |
2000-06-27 |
Lion Corp |
粒状組成物、錠剤及び粒状組成物の製造方法
|
|
GB9908921D0
(en)
|
1999-04-19 |
1999-06-16 |
Britannia Pharmaceuticals Ltd |
Spray dispenser for opiod antagonists
|
|
FR2817847B1
(fr)
|
2000-12-08 |
2003-03-28 |
Tebro |
Dispositif de distribution de produit fluide ou pulverulent
|
|
ITMI20012174A1
(it)
*
|
2001-10-18 |
2003-04-18 |
Univ Parma |
Polvere per somministrazione nasale di farmaci
|
|
GB0201367D0
(en)
|
2002-01-22 |
2002-03-13 |
Ml Lab Plc |
Composition
|
|
WO2004054511A2
(en)
|
2002-12-13 |
2004-07-01 |
The Regents Of The University Of California |
Analgesic combination comprising nalbuphine
|
|
EP2343045A3
(en)
*
|
2003-02-24 |
2011-09-21 |
Pharmaceutical Productions Inc. |
Transmucosal drug delivery system
|
|
CN100471497C
(zh)
|
2003-06-25 |
2009-03-25 |
中国人民解放军军事医学科学院毒物药物研究所 |
盐酸纳洛酮鼻粉剂
|
|
CN100515511C
(zh)
|
2003-10-09 |
2009-07-22 |
株式会社;生命科学活效 |
鼻腔用粉状药剂施药装置
|
|
CN1640402A
(zh)
|
2004-01-02 |
2005-07-20 |
广东奇方药业有限公司 |
一种稳定的纳洛酮粉针剂
|
|
IL159729A0
(en)
|
2004-01-06 |
2004-06-20 |
Doron I Friedman |
Non-aqueous composition for oral delivery of insoluble bioactive agents
|
|
US9895444B2
(en)
|
2004-08-25 |
2018-02-20 |
Aegis Therapeutics, Llc |
Compositions for drug administration
|
|
CN1305474C
(zh)
*
|
2004-10-13 |
2007-03-21 |
北京国药龙立生物医药新技术有限公司 |
盐酸纳美芬鼻腔给药制剂
|
|
CN1615867A
(zh)
|
2004-10-22 |
2005-05-18 |
北京阳光润禾科技有限公司 |
注射用盐酸纳洛酮冻干粉针制剂
|
|
CN1781479B
(zh)
|
2004-12-02 |
2010-06-30 |
和记黄埔医药企业有限公司 |
一种马蔺子素分散体系及其制备方法
|
|
US20080317863A1
(en)
|
2005-02-10 |
2008-12-25 |
Christer Nystrom |
Pharmaceutical Compositions Useful in the Transmucosal Administration of Drugs
|
|
KR101233235B1
(ko)
|
2005-08-26 |
2013-02-15 |
에스케이케미칼주식회사 |
초기 용출율이 개선된 프란루카스트 고체분산체의 약제학적조성물 및 그의 제조방법
|
|
CN1939358A
(zh)
|
2005-09-30 |
2007-04-04 |
江西本草天工科技有限责任公司 |
肿节风分散片
|
|
CN1813739A
(zh)
|
2005-11-25 |
2006-08-09 |
王颖 |
一种注射用盐酸纳美芬冻干粉针制剂
|
|
PL2061427T3
(pl)
|
2006-09-15 |
2011-12-30 |
Echo Pharmaceuticals Bv |
Granulat zawierający substancję farmaceutycznie aktywną i emulgator oraz sposób jego wytwarzania
|
|
WO2009040595A1
(en)
|
2007-09-28 |
2009-04-02 |
Wockhardt Research Centre |
Multi-dose pharmaceutical composition of analgesic for nasal administration
|
|
CN102083467B
(zh)
|
2008-03-11 |
2013-12-25 |
Aska制药株式会社 |
固体分散体及其药物组合物、以及它们的制备方法
|
|
US20090246256A1
(en)
|
2008-03-27 |
2009-10-01 |
Al-Ghananeem Abeer M |
Compositions and Methods for Transmucosal Delivery of Lofexidine
|
|
US8715715B2
(en)
|
2008-11-03 |
2014-05-06 |
Nal Pharmaceuticals Ltd. |
Dosage form for insertion into the mouth
|
|
EP2266563A1
(en)
|
2009-06-11 |
2010-12-29 |
Charité-Universitätsmedizin Berlin (Charité) |
Use of opioid receptor antagonists for acute treatment of paraphilic arousal states
|
|
WO2011013003A2
(en)
|
2009-07-31 |
2011-02-03 |
Shin Nippon Biomedical Laboratories, Ltd. |
Intranasal granisetron and nasal applicator
|
|
DK2480197T3
(en)
|
2009-09-25 |
2016-01-25 |
Reddys Lab Ltd Dr |
Compositions containing triptanforbindelser
|
|
CN102068697B
(zh)
*
|
2010-12-30 |
2013-10-16 |
宜昌人福药业有限责任公司 |
含有阿片类镇痛剂和阿片受体拮抗剂的药用组合物
|
|
MY194947A
(en)
|
2011-05-13 |
2022-12-27 |
Euro Celtique Sa |
Intranasal pharmaceutical dosage forms comprising naloxone
|
|
EP3248642B1
(en)
|
2012-06-28 |
2020-04-08 |
The Government of The United States of America as represented by The Secretary of The Department of Health and Human Services |
Nasal dry powder delivery system for vaccines and other treatment agents
|
|
FR3007992B1
(fr)
|
2013-07-05 |
2018-01-26 |
Aptar France Sas |
Dispositif de distribution de produit fluide ou pulverulent.
|
|
WO2015095389A1
(en)
|
2013-12-18 |
2015-06-25 |
Aegis Therapeutics, Llc |
Compositions for drug administration
|
|
CA2875384A1
(en)
|
2013-12-20 |
2015-06-20 |
AntiOP, Inc. |
Intranasal naloxone compositions and methods of making and using same
|
|
US10085937B2
(en)
|
2014-03-14 |
2018-10-02 |
Adapt Pharma Limited |
Nasal drug products and methods of their use
|
|
US9480644B2
(en)
|
2014-03-14 |
2016-11-01 |
Opiant Pharmaceuticals, Inc. |
Nasal drug products and methods of their use
|
|
US11135155B2
(en)
|
2014-07-08 |
2021-10-05 |
Hikma Pharmaceuticals Usa Inc. |
Liquid naloxone spray
|
|
EP3174534A1
(en)
|
2014-08-01 |
2017-06-07 |
KRKA, d.d., Novo mesto |
Pharmaceutical formulation comprising an opioid agonist and an opioid antagonist prepared by melt granulation using lipid esters
|
|
EP3220893B1
(en)
|
2014-11-14 |
2023-06-07 |
Asoltech Srl |
Composition based on coq10
|
|
CN104547220A
(zh)
|
2014-12-30 |
2015-04-29 |
陈宏� |
一种治疗儿童视觉疲劳的中药组合物及其制剂
|
|
US10166197B2
(en)
*
|
2015-02-13 |
2019-01-01 |
St. John's University |
Sugar ester nanoparticle stabilizers
|
|
BR112017014994B1
(pt)
|
2015-02-17 |
2023-12-19 |
Eli Lilly And Company |
Composições em pó nasal para tratamento de hipoglicemia, seu uso e seus métodos de preparação, e aplicador nasal
|
|
AU2015390471A1
(en)
|
2015-04-08 |
2017-11-09 |
John KLASSEN |
Pharmaceutical compositions of polyanionic and non-ionic cyclodextrin-based dendrimers and uses thereof
|
|
DK3400066T3
(da)
*
|
2016-01-08 |
2021-10-18 |
Ohio State Innovation Foundation |
Behandlinger og forebyggelse af neonatalt opioidt abstinenssyndrom
|
|
WO2017158439A1
(en)
|
2016-03-16 |
2017-09-21 |
Omegatri As |
Powders and tablets comprising omega-3 fatty acid derivatives and methods for their production
|
|
KR102634829B1
(ko)
|
2016-06-24 |
2024-02-07 |
오피언트 파마슈티컬스, 인코퍼레이티드 |
알코올 사용 장애의 치료용 조성물, 장치 및 방법
|
|
JP7187035B2
(ja)
*
|
2016-08-03 |
2022-12-12 |
アールイーエムディー バイオセラピューティクス，インコーポレイテッド |
癌を治療するためのグルカゴン受容体アンタゴニストとｐｉ３ｋ経路阻害剤との組み合わせ
|
|
JP2020500081A
(ja)
|
2016-09-28 |
2020-01-09 |
クロノ セラピューティクス インコーポレイテッドＣｈｒｏｎｏ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｉｎｃ． |
オピオイドを送達する経皮薬剤送達装置
|
|
WO2018064672A1
(en)
|
2016-09-30 |
2018-04-05 |
Opiant Pharmaceuticals, Inc. |
Treatment with intranasal naloxone
|
|
US20180092839A1
(en)
|
2016-10-03 |
2018-04-05 |
Lance L. Gooberman |
Medicated spray for treatment of substance abuse, overdose, addiction and impulse control disorders
|
|
CA3043028A1
(en)
|
2016-11-09 |
2018-05-17 |
Opiant Pharmaceuticals, Inc. |
Compositions, devices, and methods for the treatment of opioid-receptor-mediated conditions
|
|
IL312012A
(en)
|
2016-11-18 |
2024-06-01 |
Opiant Pharmaceuticals Inc |
Compositions and methods for the treatment of opioid overdose
|
|
CN106361700A
(zh)
*
|
2016-11-25 |
2017-02-01 |
威海恒基伟业信息科技发展有限公司 |
盐酸纳美芬鼻腔给药制剂
|
|
US10394770B2
(en)
|
2016-12-30 |
2019-08-27 |
General Electric Company |
Methods and systems for implementing a data reconciliation framework
|
|
WO2018148382A1
(en)
|
2017-02-10 |
2018-08-16 |
Mucodel Pharma Llc |
Chemically stable compositions of a pharmaceutical active agent in a multi-chambered delivery system for mucosal delivery
|
|
EP3668490A4
(en)
|
2017-08-20 |
2021-06-09 |
Formulex Pharma Innovations Ltd. |
Dry powder compositions for intranasal delivery
|
|
US20180193332A1
(en)
|
2017-10-09 |
2018-07-12 |
Adapt Pharma Operations Limited |
Low-temperature stable opioid antagonist solutions
|
|
CN109953952A
(zh)
*
|
2017-12-25 |
2019-07-02 |
王旭宁 |
盐酸纳美芬鼻腔给药制剂
|